Researchers develop colon-targeted drug delivery system
Hyderabad: A team of researchers from Andhra Pradesh, in collaboration with scientists from Saudi Arabia and the UAE, has developed a novel drug delivery system for colon cancer using cross-linked nanoparticles derived from mastic gum (MG)—a natural resin.
Tired of too many ads? go ad free now
Their findings were published in 'Nature Scientific Reports' under the title 'Enhanced colon-targeted drug delivery through development of 5-fluorouracil-loaded cross-linked mastic gum nanoparticles.'
The study, led by Nawaz Mahammed and T Reshma of Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, centres on the targeted delivery of 5-fluorouracil (5-FU)—a widely used chemotherapeutic agent—directly to the colon.
The goal is to maximise therapeutic efficacy while minimising systemic toxicity and off-target effects. Conventional oral formulations of 5-FU are prone to premature degradation in the upper gastrointestinal tract, limiting their utility for colon-specific cancers.
Encapsulation efficiency
The team formulated cross-linked mastic gum nanoparticles capable of encapsulating 5-FU and releasing it in a controlled, zero-order kinetic profile—ensuring a consistent and sustained release rate over time.
The formulation demonstrated an encapsulation efficiency of 83.5%, with an average particle size of 240 nanometres.
Importantly, 95.2% of the drug was released in a colon-targeted manner, underscoring the platform's promise for site-specific drug delivery.
Characterisation techniques, including fourier transform infrared spectroscopy, confirmed successful cross-linking of the MG, while scanning electron microscopy revealed uniformly spherical nanoparticles—features that contribute to the system's stability and targeting precision.
Tired of too many ads? go ad free now
Among the various formulations evaluated, the cross-linked MG nanoparticles emerged as the most effective, demonstrating both structural integrity and optimal drug release characteristics. The study underscores the therapeutic potential of this approach in enhancing the efficacy of chemotherapy for colorectal cancer while reducing systemic exposure and associated side-effects.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
19 hours ago
- NDTV
Astronomers Baffled By Mysterious Object Emitting X-Rays And Radio Waves In Milky Way
Astronomers have stumbled upon a perplexing celestial enigma within our very own Milky Way galaxy. An international team of researchers has reported the discovery of a peculiar object exhibiting a unique behaviour: emitting X-rays in sync with bursts of radio waves, all in a repeating cycle of approximately 44 minutes. According to the study published in the journal Nature, this unprecedented observation has led scientists to classify the object as unlike any known entity within our galaxy. Located 15,000 light-years away in a star-rich region of the Milky Way, this enigmatic object, dubbed ASKAP J1832-0911, could potentially be a highly magnetised remnant of a dead star, such as a neutron star or white dwarf. However, the possibility of it being an entirely new and exotic phenomenon remains on the table. View this post on Instagram A post shared by NASA Chandra X-ray Observatory (@nasachandraxray) "This object is unlike anything we have seen before," team leader and Curtin University researcher Zieng (Andy) Wang said in a statement. The serendipitous discovery occurred during a routine observation of a supernova remnant by NASA's Chandra X-ray Observatory. Researchers were taken aback when they detected X-ray emissions emanating from the same source as previously observed long-period radio transients, which are rare objects that cycle through radio signals over extended periods. The correlation between the X-ray and radio wave emissions, coupled with other unusual characteristics, has deepened the mystery surrounding ASKAP J1832-0911. The object's hyperactive phase, during which it emits noticeable X-rays, appears to last for about a month, followed by a period of quiescence. This intermittent behavior suggests that similar objects might be lurking undetected in other parts of the galaxy, waiting to be discovered. While astronomers have pinpointed the object's location, its association with the nearby supernova remnant remains uncertain due to the vast distances involved. Further investigations are underway to unravel the true nature of ASKAP J1832-0911 and to explore the possibility of uncovering more of these enigmatic objects scattered across the cosmos.
Time of India
a day ago
- Time of India
Researchers develop colon-targeted drug delivery system
Hyderabad: A team of researchers from Andhra Pradesh, in collaboration with scientists from Saudi Arabia and the UAE, has developed a novel drug delivery system for colon cancer using cross-linked nanoparticles derived from mastic gum (MG)—a natural resin. Tired of too many ads? go ad free now Their findings were published in 'Nature Scientific Reports' under the title 'Enhanced colon-targeted drug delivery through development of 5-fluorouracil-loaded cross-linked mastic gum nanoparticles.' The study, led by Nawaz Mahammed and T Reshma of Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, centres on the targeted delivery of 5-fluorouracil (5-FU)—a widely used chemotherapeutic agent—directly to the colon. The goal is to maximise therapeutic efficacy while minimising systemic toxicity and off-target effects. Conventional oral formulations of 5-FU are prone to premature degradation in the upper gastrointestinal tract, limiting their utility for colon-specific cancers. Encapsulation efficiency The team formulated cross-linked mastic gum nanoparticles capable of encapsulating 5-FU and releasing it in a controlled, zero-order kinetic profile—ensuring a consistent and sustained release rate over time. The formulation demonstrated an encapsulation efficiency of 83.5%, with an average particle size of 240 nanometres. Importantly, 95.2% of the drug was released in a colon-targeted manner, underscoring the platform's promise for site-specific drug delivery. Characterisation techniques, including fourier transform infrared spectroscopy, confirmed successful cross-linking of the MG, while scanning electron microscopy revealed uniformly spherical nanoparticles—features that contribute to the system's stability and targeting precision. Tired of too many ads? go ad free now Among the various formulations evaluated, the cross-linked MG nanoparticles emerged as the most effective, demonstrating both structural integrity and optimal drug release characteristics. The study underscores the therapeutic potential of this approach in enhancing the efficacy of chemotherapy for colorectal cancer while reducing systemic exposure and associated side-effects.
India Today
2 days ago
- India Today
Study uncovers the digestibility problem in protein bars
Protein bars are a go-to snack for health-conscious consumers, often marketed as "high in protein" and packed with a new study suggests that, despite their labels, many of these products may fall short of delivering real nutritional value, especially when it comes to the quality of protein they from the Hungarian University of Agriculture and Life Sciences in Budapest analysed more than 1,600 commercially available protein bars using public data from In the study published in Scientific Reports, they found that 81% of these bars met the European Union's standard for being labelled "high in protein," meaning over 20% of their calories came from a deeper dive into how the body actually digests and uses this protein revealed more concerning assess protein quality, scientists selected four representative bars with varying protein sources: plant-based (pea and rice), animal-based (milk), and two mixed-source bars combining milk, egg, collagen, and soy. These bars were tested using a lab method that simulates human findings were consistent: even bars made with high-quality proteins showed reduced digestibility when consumed as part of the full product, compared to when the same proteins were tested on their own. The study found that 81% of these bars met the European Union's standard for being labelled advertisementThe highest-performing bar, made solely with milk proteins, still scored below the threshold recommended by the Food and Agriculture Organisation (FAO) for claiming high protein likely reason, the researchers noted, is that additional ingredients like sugars, fats, and fibres, commonly used to improve texture and taste, could interfere with the body's ability to absorb essential amino study raises important questions about how we evaluate protein-rich foods. While these bars may be convenient, experts caution against relying on them as a primary protein consumers are encouraged to look beyond the label. "It's not just about how much protein a bar contains. The type and digestibility of that protein matters too," the researchers findings highlight a growing need for clearer labelling and more rigorous standards when it comes to protein claims on processed foods.
